Watson 369 5 mg (Loxapine 5 mg)

This pill with imprint "Watson 369 5 mg" is White, Capsule-shape and has been identified as Loxapine succinate 5 mg. It is manufactured by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Loxapine succinate

Imprint:

Watson 369 5 mg

Strength:

5 mg

Color:

White

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Miscellaneous antipsychotic agents

Pregnancy Category:

N - Not classified

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

National Drug Code (NDC):

00591-0369

Inactive Ingredients:

lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.